Is There a TIME and Place for Thrombolytics in Malignant Pleural Effusions?

Am J Respir Crit Care Med. 2018 Feb 15;197(4):422-423. doi: 10.1164/rccm.201710-2044ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Fibrinolytic Agents
  • Humans
  • Pleural Effusion*
  • Pleural Effusion, Malignant*
  • Urokinase-Type Plasminogen Activator

Substances

  • Fibrinolytic Agents
  • Urokinase-Type Plasminogen Activator